Low vitamin D speeds age-related cognitive decline

  • On average, older adults with low levels of vitamin D showed much faster decline in episodic memory and executive function.
  • Older adults with dementia had significantly lower levels of vitamin D compared to those with MCI or normal cognition.
  • Low vitamin D was more common in African-Americans and Hispanics, compared to whites.

A study involving 382 older adults (average age 75) followed for around five years, has found that those who don’t get enough vitamin D may experience cognitive decline at a much faster rate than people who have adequate vitamin D.

Participants included 17.5% with dementia at the beginning of the study, 32.7% with MCI, and 49.5% cognitively healthy.

Those with dementia had lower levels of vitamin D than the other two groups.

While some people with low vitamin D didn’t show any cognitive decline and some with adequate vitamin D declined quickly, people with low vitamin D on average declined two to three times as fast as those with adequate vitamin D, in two crucial cognitive domains: episodic memory and executive function. Semantic memory and visuospatial ability were not significantly affected.

Factors such as age, gender, education, BMI, season of blood draw, vascular risk, and presence of the 'Alzheimer's gene', ApoE4, were controlled for.

Unlike previous studies of vitamin D and dementia, the participants were racially and ethnically diverse and included whites (41%), African Americans (30%), and Hispanics (25%). Nearly two-thirds (61%) had low vitamin D levels in their blood, including 54% of the whites and 70% of the African-Americans and Hispanics.

Vitamin D is primarily obtained through sun exposure. Accordingly, people with darker skin are more likely to have low levels of vitamin D because melanin blocks ultra-violet rays.

It remains to be seen whether Vitamin D supplements could slow cognitive decline.

http://www.futurity.org/vitamin-d-cognitive-decline-1003932/

 

Reference: 

Related News

A review of three high quality trials comparing the putative benefits of omega-3 fatty acids for preventing age-related cognitive decline, has concluded that there is no evidence that taking fish oil supplements helps fight cognitive decline.

While the ‘Alzheimer’s gene’ is relatively common — the ApoE4 mutation is present in around 15% of the population — having two copies of the mutation is, thankfully, much rarer, at around 2%.

Dementia is a progressive illness, and its behavioral and psychological symptoms are, for caregivers, the most difficult symptoms to manage.

A study designed to compare the relative benefits of exercise and diet control on Alzheimer’s pathology and cognitive performance has revealed that while both are beneficial, exercise is of greater benefit in reducing Alzheimer’s pathology and cognitive impairment.

I have reported previously on research suggesting that rapamycin, a bacterial product first isolated from soil on Easter Island and used to help transplant patients prevent organ rejection, might improve learning and memory.

Following on from mouse studies, a human study has investigated whether caffeine can help prevent older adults with mild cognitive impairment from progressing to dementia.

A study involving those with a strong genetic risk of developing Alzheimer’s has found that the first signs of the disease can be detected 25 years before symptoms are evident.

A number of studies have come out in recent years linking age-related cognitive decline and dementia risk to inflammation and infection (put inflammation into the “Search this site” box at the top of the page and you’ll see what I mean). New research suggests one important mechanism.

I’ve reported before on the evidence suggesting that carriers of the ‘Alzheimer’s gene’, APOE4, tend to have smaller brain volumes and perform worse on cognitive tests, despite being cognitively ‘normal’.

A new study, involving 1,219 dementia-free older adults (65+), has found that the more omega-3 fatty acids the person consumed, the lower the level of beta-amyloid in the blood (a proxy for brain levels).

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news